ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,918.80
      -2.26%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.57
      -0.38%
      Bitcoin
      60,196.93
      -0.66%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. AQSE
      6. Apollon Formularies plc (APOL)

      7. Apollon Formularies plc (APOL) News

      APOL

      Apollon Formularies (APOL)

      Apollon Formularies plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AQSE:APOL
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      02/20/20245:59AMUK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
      01/02/20243:18AMUK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
      12/05/20236:59AMUK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
      11/21/20236:51AMUK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
      09/29/20232:00AMUK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
      09/19/20234:18AMUK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
      08/03/20235:51AMUK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
      08/02/20237:19AMUK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
      07/24/20236:00AMUK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
      06/30/202312:32PMUK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
      05/10/202312:05PMUK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
      04/11/20239:00AMUK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
      03/21/20238:00AMUK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
      03/15/20233:00AMUK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
      01/12/20232:00AMUK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
      12/30/20227:37AMUK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
      12/02/20222:00AMUK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
      09/30/20224:50AMUK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
      09/13/20222:02AMUK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
      08/02/20224:11AMUK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
      07/26/20222:00AMUK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
      06/30/202211:29AMUK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
      06/30/20227:33AMUK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
      06/17/20228:23AMUK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
      05/05/20227:07AMUK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
      03/02/20222:01AMUK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
      02/09/20222:00AMUK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
      02/03/20221:59AMUK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
      01/27/20222:00AMUK RegulatoryApollon Formularies plc Chief Science Officer Appointed as Board DirectorAQSE:APOLApollon Formularies plc
       Showing the most relevant articles for your search:AQSE:APOL